USD 0.09
(10.97%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 6.68 Million USD | 18.4% |
2023 | 5.64 Million USD | 47.15% |
2022 | 3.83 Million USD | -24.51% |
2021 | 5.08 Million USD | 401.94% |
2020 | 1.01 Million USD | -89.91% |
2019 | 10.04 Million USD | 0.91% |
2018 | 9.95 Million USD | 64.04% |
2017 | 6.06 Million USD | 46.01% |
2016 | 4.15 Million USD | -34.26% |
2015 | 6.32 Million USD | 24.47% |
2014 | 5.07 Million USD | -5.61% |
2013 | 5.38 Million USD | -7.37% |
2012 | 5.8 Million USD | 11.92% |
2011 | 5.19 Million USD | -9.81% |
2010 | 5.75 Million USD | -26.29% |
2009 | 7.8 Million USD | -14.78% |
2008 | 9.16 Million USD | 142.78% |
2007 | 3.77 Million USD | 32.17% |
2006 | 2.85 Million USD | 57.21% |
2005 | 1.81 Million USD | -46.03% |
2004 | 3.36 Million USD | 0.92% |
2003 | 3.33 Million USD | -7.67% |
2002 | 3.61 Million USD | -26.97% |
2001 | 4.94 Million USD | 17.5% |
2000 | 4.2 Million USD | -20.59% |
1999 | 5.3 Million USD | 26.19% |
1998 | 4.2 Million USD | 50.0% |
1997 | 2.8 Million USD | -6.67% |
1996 | 3 Million USD | 36.36% |
1995 | 2.2 Million USD | -8.33% |
1994 | 2.4 Million USD | 84.62% |
1993 | 1.3 Million USD | 1200.0% |
1992 | 100 Thousand USD | 0.0% |
1991 | - USD | 0.0% |
1990 | - USD | 0.0% |
1989 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q4 | 6.68 Million USD | -4.69% |
2024 Q1 | 1.8 Million USD | -68.06% |
2024 Q3 | 7.01 Million USD | 1.57% |
2024 Q2 | 6.9 Million USD | 282.94% |
2023 FY | 5.64 Million USD | 47.15% |
2023 Q1 | 3.51 Million USD | -8.46% |
2023 Q4 | 5.64 Million USD | -4.79% |
2023 Q3 | 5.93 Million USD | 9.34% |
2023 Q2 | 5.42 Million USD | 54.4% |
2022 Q1 | 4.77 Million USD | -6.0% |
2022 Q3 | 4.15 Million USD | -7.04% |
2022 Q2 | 4.47 Million USD | -6.47% |
2022 FY | 3.83 Million USD | -24.51% |
2022 Q4 | 3.83 Million USD | -7.63% |
2021 Q2 | 9.18 Million USD | -3.72% |
2021 FY | 5.08 Million USD | 401.94% |
2021 Q1 | 9.53 Million USD | 841.39% |
2021 Q3 | 8.87 Million USD | -3.39% |
2021 Q4 | 5.08 Million USD | -42.68% |
2020 Q2 | 11.4 Million USD | -4.98% |
2020 Q1 | 11.99 Million USD | 19.47% |
2020 Q3 | 12.57 Million USD | 10.3% |
2020 Q4 | 1.01 Million USD | -91.94% |
2020 FY | 1.01 Million USD | -89.91% |
2019 Q3 | 8.4 Million USD | -2.42% |
2019 Q4 | 10.04 Million USD | 19.43% |
2019 FY | 10.04 Million USD | 0.91% |
2019 Q1 | 8.59 Million USD | -13.61% |
2019 Q2 | 8.61 Million USD | 0.23% |
2018 Q4 | 9.95 Million USD | -2.3% |
2018 FY | 9.95 Million USD | 64.04% |
2018 Q1 | 10.91 Million USD | 79.92% |
2018 Q3 | 10.18 Million USD | -2.75% |
2018 Q2 | 10.47 Million USD | -4.04% |
2017 Q4 | 6.06 Million USD | -6.89% |
2017 FY | 6.06 Million USD | 46.01% |
2017 Q1 | 4.05 Million USD | -2.33% |
2017 Q2 | 3.98 Million USD | -1.92% |
2017 Q3 | 6.51 Million USD | 63.7% |
2016 Q4 | 4.15 Million USD | -1.83% |
2016 FY | 4.15 Million USD | -34.26% |
2016 Q3 | 4.23 Million USD | -15.33% |
2016 Q2 | 4.99 Million USD | -1.14% |
2016 Q1 | 5.05 Million USD | -20.0% |
2015 Q3 | 6.39 Million USD | 4.87% |
2015 Q1 | 5.81 Million USD | 14.5% |
2015 Q2 | 6.1 Million USD | 4.94% |
2015 FY | 6.32 Million USD | 24.47% |
2015 Q4 | 6.32 Million USD | -1.22% |
2014 Q1 | 5.41 Million USD | 0.68% |
2014 Q4 | 5.07 Million USD | -4.37% |
2014 Q2 | 5.39 Million USD | -0.39% |
2014 Q3 | 5.31 Million USD | -1.59% |
2014 FY | 5.07 Million USD | -5.61% |
2013 Q2 | 5.8 Million USD | -1.39% |
2013 Q4 | 5.38 Million USD | -7.83% |
2013 Q3 | 5.83 Million USD | 0.55% |
2013 FY | 5.38 Million USD | -7.37% |
2013 Q1 | 5.88 Million USD | 1.36% |
2012 Q1 | 5.73 Million USD | 10.45% |
2012 Q3 | 6.13 Million USD | 13.13% |
2012 FY | 5.8 Million USD | 11.92% |
2012 Q4 | 5.8 Million USD | -5.32% |
2012 Q2 | 5.42 Million USD | -5.41% |
2011 FY | 5.19 Million USD | -9.81% |
2011 Q4 | 5.19 Million USD | -3.15% |
2011 Q3 | 5.35 Million USD | 3.14% |
2011 Q2 | 5.19 Million USD | -6.88% |
2011 Q1 | 5.58 Million USD | -3.04% |
2010 Q1 | 8.15 Million USD | 4.44% |
2010 FY | 5.75 Million USD | -26.29% |
2010 Q4 | 5.75 Million USD | -17.39% |
2010 Q3 | 6.96 Million USD | -5.88% |
2010 Q2 | 7.4 Million USD | -9.23% |
2009 FY | 7.8 Million USD | -14.78% |
2009 Q1 | 8.91 Million USD | -2.72% |
2009 Q4 | 7.8 Million USD | -11.47% |
2009 Q2 | 9.4 Million USD | 5.57% |
2009 Q3 | 8.81 Million USD | -6.27% |
2008 Q2 | 9.1 Million USD | 23.75% |
2008 Q3 | 9.13 Million USD | 0.27% |
2008 FY | 9.16 Million USD | 142.78% |
2008 Q4 | 9.16 Million USD | 0.31% |
2008 Q1 | 7.36 Million USD | 95.07% |
2007 Q1 | 3.08 Million USD | 8.13% |
2007 FY | 3.77 Million USD | 32.17% |
2007 Q4 | 3.77 Million USD | 0.56% |
2007 Q3 | 3.75 Million USD | 17.54% |
2007 Q2 | 3.19 Million USD | 3.41% |
2006 FY | 2.85 Million USD | 57.21% |
2006 Q1 | 2.36 Million USD | 30.34% |
2006 Q2 | 2.66 Million USD | 12.69% |
2006 Q3 | 3.61 Million USD | 35.41% |
2006 Q4 | 2.85 Million USD | -20.96% |
2005 Q4 | 1.81 Million USD | -17.26% |
2005 FY | 1.81 Million USD | -46.03% |
2005 Q1 | 2.95 Million USD | -12.05% |
2005 Q2 | 2.87 Million USD | -2.86% |
2005 Q3 | 2.19 Million USD | -23.66% |
2004 Q3 | 3.5 Million USD | 7.67% |
2004 Q2 | 3.25 Million USD | -9.03% |
2004 Q1 | 3.57 Million USD | 7.29% |
2004 Q4 | 3.36 Million USD | -3.97% |
2004 FY | 3.36 Million USD | 0.92% |
2003 FY | 3.33 Million USD | -7.67% |
2003 Q1 | 3.49 Million USD | -3.34% |
2003 Q3 | 3.41 Million USD | 11.41% |
2003 Q2 | 3.06 Million USD | -12.09% |
2003 Q4 | 3.33 Million USD | -2.47% |
2002 Q2 | 4.87 Million USD | -1.48% |
2002 FY | 3.61 Million USD | -26.97% |
2002 Q4 | 3.61 Million USD | -17.18% |
2002 Q3 | 4.36 Million USD | -10.48% |
2002 Q1 | 4.94 Million USD | -0.01% |
2001 Q3 | 4.21 Million USD | 15.73% |
2001 FY | 4.94 Million USD | 17.5% |
2001 Q1 | 3.77 Million USD | -10.23% |
2001 Q2 | 3.64 Million USD | -3.54% |
2001 Q4 | 4.94 Million USD | 17.25% |
2000 FY | 4.2 Million USD | -20.59% |
2000 Q2 | 5 Million USD | -5.66% |
2000 Q3 | 4.55 Million USD | -8.9% |
2000 Q4 | 4.2 Million USD | -7.6% |
2000 Q1 | 5.3 Million USD | 0.0% |
1999 Q1 | 5.1 Million USD | 21.43% |
1999 Q3 | 5.4 Million USD | 1.89% |
1999 Q4 | 5.3 Million USD | -1.85% |
1999 Q2 | 5.3 Million USD | 3.92% |
1999 FY | 5.3 Million USD | 26.19% |
1998 Q2 | 3.2 Million USD | 28.0% |
1998 Q3 | 3.4 Million USD | 6.25% |
1998 Q4 | 4.2 Million USD | 23.53% |
1998 FY | 4.2 Million USD | 50.0% |
1998 Q1 | 2.5 Million USD | -10.71% |
1997 Q2 | 2.7 Million USD | -3.57% |
1997 Q4 | 2.8 Million USD | 16.67% |
1997 FY | 2.8 Million USD | -6.67% |
1997 Q1 | 2.8 Million USD | -6.67% |
1997 Q3 | 2.4 Million USD | -11.11% |
1996 Q3 | 2.1 Million USD | 0.0% |
1996 FY | 3 Million USD | 36.36% |
1996 Q1 | 2.2 Million USD | 0.0% |
1996 Q2 | 2.1 Million USD | -4.55% |
1996 Q4 | 3 Million USD | 42.86% |
1995 Q1 | 2.3 Million USD | -4.17% |
1995 FY | 2.2 Million USD | -8.33% |
1995 Q4 | 2.2 Million USD | 0.0% |
1995 Q3 | 2.2 Million USD | -4.35% |
1995 Q2 | 2.3 Million USD | 0.0% |
1994 Q3 | 2.5 Million USD | 0.0% |
1994 Q1 | 2.1 Million USD | 61.54% |
1994 Q2 | 2.5 Million USD | 19.05% |
1994 Q4 | 2.4 Million USD | -4.0% |
1994 FY | 2.4 Million USD | 84.62% |
1993 FY | 1.3 Million USD | 1200.0% |
1993 Q3 | 800 Thousand USD | 100.0% |
1993 Q1 | 100 Thousand USD | 0.0% |
1993 Q2 | 400 Thousand USD | 300.0% |
1993 Q4 | 1.3 Million USD | 62.5% |
1992 Q4 | 100 Thousand USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 FY | 100 Thousand USD | 0.0% |
1992 Q1 | - USD | 0.0% |
1992 Q3 | 100 Thousand USD | 0.0% |
1991 FY | - USD | 0.0% |
1991 Q2 | - USD | 0.0% |
1991 Q1 | - USD | 0.0% |
1991 Q3 | - USD | 0.0% |
1991 Q4 | - USD | 0.0% |
1990 Q3 | - USD | 0.0% |
1990 FY | - USD | 0.0% |
1990 Q4 | - USD | 0.0% |
1989 Q4 | - USD | 0.0% |
1989 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Acutus Medical, Inc. | 38.47 Million USD | 82.619% |
Biotricity, Inc. | 23.87 Million USD | 71.992% |
Cell MedX Corp. | 287.46 Thousand USD | -2226.519% |
Nemaura Medical Inc. | 20.03 Million USD | 66.611% |
PetVivo Holdings, Inc. | 1.36 Million USD | -389.945% |
RetinalGenix Technologies Inc. | 506.53 Thousand USD | -1220.336% |
Sonendo, Inc. | 40.35 Million USD | 83.426% |
Telesis Bio, Inc. | 34.38 Million USD | 80.547% |
Talis Biomedical Corporation | 19.66 Million USD | 65.996% |
Viveve Medical, Inc. | 5.34 Million USD | -25.032% |